Skip to main content

Telotristat Dosage

Medically reviewed by Drugs.com. Last updated on May 31, 2024.

Applies to the following strengths: 250 mg

Usual Adult Dose for Carcinoid Tumor

250 mg orally 3 times a day

Comments:


Use: Treatment of carcinoid syndrome diarrhea in combination with somatostatin analog (SSA) therapy in patients whose diarrhea is inadequately controlled by SSA therapy

Usual Adult Dose for Carcinoid Syndrome

250 mg orally 3 times a day

Comments:


Use: Treatment of carcinoid syndrome diarrhea in combination with somatostatin analog (SSA) therapy in patients whose diarrhea is inadequately controlled by SSA therapy

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Dose Adjustments

Persistent/severe/worsening abdominal pain occurring during use: Discontinue treatment.

Severe constipation occurring during use: Discontinue treatment.

Precautions

CONTRAINDICATIONS: None.

Safety and efficacy have not been established in pediatric patients.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:


Monitoring:

Patient advice:

Frequently asked questions

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.